La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Ontario1445
Ram K. Mishra12
Ontario Sauf Ram K. Mishra" 1436
Ram K. Mishra Sauf Ontario" 3
Ontario Et Ram K. Mishra 9
Ontario Ou Ram K. Mishra 1448
Corpus8669
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
000D90 Jovana Lubarda [Canada] ; Sarah E. Groleau ; Nancy Thomas ; Mark A. Ferro ; Ram K. Mishra ; Joseph P. GabrieleDysregulation of novel catecholamine-regulated protein 40 (CRP40) in Parkinson's disease patients.
001E69 Joseph Gabriele [Canada] ; Giuseppe F. Pontoriero [Canada] ; Nancy Thomas [Canada] ; Christy A. Thomson ; Kevin Skoblenick [Canada] ; Zdenek B. Pristupa [Canada] ; Ram K. Mishra [Canada]Cloning, characterization, and functional studies of a human 40-kDa catecholamine-regulated protein: implications in central nervous system disorders
002666 Jessica M. Castellano [Canada] ; Jody Batrynchuk [Canada] ; Kristine Dolbeare [États-Unis] ; Vaneeta Verma [Canada] ; Amandeep Mann [Canada] ; Kevin J. Skoblenick [Canada] ; Rodney L. Johnson [États-Unis] ; Ram K. Mishra [Canada]MIF-1 and its peptidomimetic analogs attenuate haloperidol-induced vacuous chewing movements and modulate apomorphine-induced rotational behavior in 6-hydroxydopamine-lesioned rats
002F14 Willard J. Costain [Canada] ; Ram K. Mishra [Canada]PLG regulates hnRNP-L expression in the rat striatum and pre-frontal cortex: identification by ddPCR
003339 Eric R. Marcotte [Canada] ; Anita Chugh [Canada] ; Cia Barlas [Canada] ; Ram K. Mishra [Canada]Differential regulation of striatal G protein levels following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration in C57 BL/6 mice
003423 Michael C. Ott [Canada] ; Willard J. Costain [Canada] ; Ram K. Mishra [Canada] ; Rodney L. Johnson [États-Unis]l-Prolyl-l-leucyl-glycinamide and its peptidomimetic analog 3( R )-[(2( S )-pyrrolidylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide (PAOPA) attenuate haloperidol-induced c-fos expression in the striatum☆
005026 Ram K. Mishra [Canada]CNS Dopamine Receptors: Effect of Prolyl-Leucyl-Glycinamide and Solubilization
005060 Chiu Simon [Canada] ; Wong Yu-Wah [Canada] ; Y. P. Wan [États-Unis] ; Pauline Chiu [Canada] ; Ram K. Mishra [Canada]Are the pharmacological effects of L-prolyl-L-leucylglycinamide (PLG) mediated through specific receptor mechanisms?
005088 Simon Chiu [Canada] ; Yu-Wah Wong [Canada] ; James A. Ferris [Canada] ; Rodney L. Johnson [Canada] ; Ram K. Mishra [Canada]Binding studies of L-Prolyl-L-leucyl-glycinamide (PLG), a novel antiparkinsonian agent, in normal human brain

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022